No Data
No Data
Huakang shares (605077.SH): Subsidiary received an administrative penalty decision letter from Weifang Ecological Environment Bureau.
On July 18th, Gelunhui reported that Huakang Stock (605077.SH) announced that its wholly-owned subsidiary Gaomi Tongli Sugar Co., Ltd. (referred to as 'Gaomi Tongli') received the 'Administrative Penalty Decision' (Wei Environment Penalty [2024]GM510) issued by the Weifang Ecological Environment Bureau.
Huakang Pharmaceutical to Set Up 35 Million Yuan JV for Xylose, Xylose Mother Liquor Production
Huakang Corporation (605077.SH) plans to establish a joint venture company to promote the industrialization project of comprehensive utilization of semi-cellulose resources.
Huakang Co., Ltd. (605077.SH) announced that in March 2024, the company signed a strategic cooperation framework agreement with the People's Government of Gaoxian County, Yibin City, Sichuan Province, focusing on the development of traditional Chinese medicine resources, the promotion of national Traditional Chinese medicine culture and the construction of a Chinese medicine health industry base.
Huakang Co., Ltd. (605077.SH): Jointly established a new company and signed an Investment Cooperation Agreement.
On July 16th, Gelunhui reported that Huakang Stock (605077.SH) signed an Investment Agreement for Industrialization of Comprehensive Utilization of Hemicellulose Resources with Gaoxian People's Government of Yibin City, Sichuan Province in March 2024. The newly established company, with a registered capital of 35 million yuan, will be jointly funded by Huakang Stock, Yibin Siliya, and Yibin Yatai in order to fully utilize each other's industrial advantages and promote the industrialization project for comprehensive utilization of hemicellulose resources in Gaoxian. The Investment Cooperation Agreement was also signed. The company held its 17th meeting of the sixth Board of Directors on July 16, 2024, and reviewed the proposal.
Returns On Capital At Zhejiang Huakang Pharmaceutical (SHSE:605077) Paint A Concerning Picture
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
No Data